New Edge Advisors, LLC Ocugen, Inc. Transaction History
New Edge Advisors, LLC
- $18.3 Billion
- Q2 2025
A detailed history of New Edge Advisors, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 36,814 shares of OCGN stock, worth $62,951. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,814
Previous 12,354
197.99%
Holding current value
$62,951
Previous $8,000
337.5%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding OCGN
# of Institutions
112Shares Held
64.6MCall Options Held
604KPut Options Held
253K-
Black Rock Inc. New York, NY17.9MShares$30.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.8MShares$25.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.06MShares$8.65 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$7.1 Million0.17% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$5.96 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $370M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...